Background and aims
Must and Anderson, 1 in this issue of the journal, have described the basis of body mass index (BMI) for age for the assessment of weight status in children and adolescents. The aims of this short article are to summarise the evidence base on the diagnostic accuracy of BMI, and to expand on what we achieve when defining paediatric obesity on the basis of a high BMI for age. A high BMI for age is not 'obesity' (a high body fat content associated with increased morbidity), per se but a diagnostic test for obesity. Similarly, in adults a BMI430 kg/m 2 is not obesity, but a positive diagnostic test for obesity. It is also widely stated that 'BMI does not predict body fat content accurately'. This is true, 2-5 but should not be used to damn the diagnostic ability of BMI because it is not directly relevant to the issue of diagnosis of obesity. When diagnosing or defining obesity, we do not need to estimate body fat content precisely; rather we simply need to establish with confidence that any child defined as obese has a high body fat content relative to his/her peers. There are two main components to the issue of diagnostic accuracy: how well does a high BMI for age diagnose the fattest children in the population? Are children at high BMI for age at greater risk of morbidity than their peers at lower BMI for age?
Evidence base on diagnostic accuracy
In order to produce an evidence-based clinical guideline, 6 a systematic review and critical appraisal of diagnostic studies in paediatric obesity was carried out, with published evidence up to end 2001 included. 6, 7 These studies were all concerned with the question of whether a high BMI for age (relative to national BMI reference data) was diagnostic of a high body fat content. All had similar design in that samples of children and adolescents had body fat content estimated by a non-reference method (DEXA, skinfold thickness, or impedance) in order to identify the fattest children in the sample, the 'true positives'. The ability of different cutoffs in the BMI distribution to identify the fattest children in the sample correctly was assessed by calculation of sensitivity, specificity, and predictive values. For our systematic review and critical appraisal, we identified nine high-quality published studies on this topic to the end of 2001, which represented a moderately large and consistent body of evidence. 6, 7 To summarise this evidence, a high BMI for age relative to national BMI reference data was consistently associated with high specificity (low false positive rate) and a low-moderate sensitivity (moderate-high false negative rate), which was dependent on the precise cutoff chosen. 7 The high specificity is a major advantage for clinical use, minimising risk of identification and treatment of patients who are not excessively fat, and has long been recognised as providing confidence in clinical diagnosis. [8] [9] [10] Low-moderate sensitivity is problematic for public health applications such as surveillance of obesity, 10 since relatively large numbers of children with high body fat content will 'test negative', and also a major limitation of BMI as an obesity definition in adults.
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Diagnostic accuracy of national and 'international' obesity definitions
Diagnostic accuracy of BMI for age depends on whether it is defined relative to national BMI reference data, or to the 'international' or 'IOTF' definitions of paediatric overweight and obesity. 12 Four published studies [13] [14] [15] [16] have now made a direct comparison of the diagnostic ability of cutoffs based on national reference data (from the US, UK, and Singapore) with those recommended by the IOTF. All four found that the sensitivity of the IOTF obesity definition was much lower than that of definitions based on national reference data (such as BMI X95th percentile). Up to 40-50% of the fattest children were not identified as obese by the IOTF approach. [13] [14] [15] [16] These studies also reported that the sensitivity of the IOTF definition was highly sex-specific. In the UK, for example, use of the IOTF approach has much lower sensitivity in boys than girls, 13 leading to the erroneous conclusion that obesity is more prevalent in girls than boys. 11 The IOTF definitions of childhood obesity were apparently not designed for clinical applications such as diagnosis of obesity, and such applications are not supported by the evidence described above, but they remain widely recommended and used clinically, at least in the UK.

Implications of limitations in diagnostic accuracy
All of the widely used definitions of obesity, which represent high BMI for age (e.g. BMI X91st or 95th percentiles of national reference data or IOTF definitions) will provide high specificity when used to define or diagnose paediatric obesity. Low-moderate sensitivity remains a concern, but less so if national reference data are used, and this is less of a problem for the purposes of clinical diagnosis.
Evidence base on the comorbidities of high BMI for age
The second issue considered by our systematic review and critical appraisal was the evidence that a high BMI for age was associated with morbidity, in the short-term (in childhood and adolescence) and long-term (in adulthood). 7 By end 2001, we had identified 65 high-quality studies on a wide variety of comorbidities of paediatric obesity: cardiovascular risk factors, psychological ill health, asthma, type 1 diabetes, inflammation, and orthopaedic problems (in childhood); obesity persistence; premature mortality; adverse social and economic outcomes; cardiovascular risk factors (in adulthood). 7 Most of these studies compared prevalence or risk of a comorbid condition in samples with high BMI for age (typically BMI X85th or 95th percentiles relative to national BMI reference data) with those at lower BMI for age (usually BMI o85th percentile). The body of evidence on comorbidities was fairly large, high quality, and consistent. 7 To summarise this evidence, children and adolescents at high BMI for age are at higher risk of a variety of morbidities, both in childhood/adolescence and in adulthood, 7 providing reassurance that a high BMI for age is clinically or biologically meaningful and not a purely statistical concept.
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It is also quite likely that in clinic populations of obese children, referred for obesity treatment, some comorbidities will be more common and/or more serious than in the 'general population' of obese children. More recent studies using the IOTF definitions of obesity have also found that risk of comorbidities is high, 18, 19 perhaps not surprisingly since the IOTF values used to define obesity are generally higher than corresponding values based on national reference data (except in early childhood). In summary, we can be confident that high BMI for age in childhood and adolescence constitutes a state of increased risk of morbidity.
What is the optimal BMI for age cutoff?
The precise cutoff in the BMI for age distribution which best defines increased risk of morbidity is a more complex issue. The comorbidities of paediatric obesity are many, varied, and subtle. It would be naive to expect any single BMI for age cutoff to perfectly define increased risk across such a wide range of morbidities, and across all populations. In paediatric populations, the levels of BMI for age which are associated with some of the psychosocial comorbidities may be culturespecific. 7 The level of BMI for age associated with some of the comorbidities is also age-and sex-specific. 7 In adults, there are substantial differences between populations/ethnic groups in the relationships between BMI-body fat content and BMI-fat distribution. For any given BMI, some populations are fatter and have a more central fat distribution. 20 This has led to the recent adoption of population-specific BMI cutoff points to define obesity in some adult populations. The research on this question in children and adolescents is less advanced, but it seems likely that such population differences are not confined to adulthood. 11, 14, 20 Ultimately, population-specific BMI cutoffs may therefore become necessary for children and adolescents. 11, 14, 20 Barriers to use of the BMI for age
Despite the large body of evidence in support of BMI for age, there remains a reluctance to use it in clinical practice. 10 This reflects a variety of failings in the education and training of health professionals, and the general lack of awareness of the impact of paediatric obesity among health professionals and families at present. 21 Lay use of the BMI for assessment of Accuracy of BMI for age JJ Reilly adult weight status is uncommon, and this is even more problematic for children and adolescents because BMI must be interpreted relative to age and sex. Nevertheless, there are some grounds for optimism: the concept of BMI for age is being disseminated increasingly widely; in clinical settings, BMI for age is usually readily understood by families when explained in the context of a percentile chart; US BMI percentile charts are readily available from the internet.
Conclusions
A large body of high quality and consistent evidence shows that a high BMI for age in paediatrics has acceptable diagnostic accuracy for a high body fat content, and denotes increased risk of morbidity. Appropriate diagnosis of paediatric obesity using the BMI for age is fundamental to our clinical and public health responses to the obesity epidemic. Greater public and professional understanding and use of the BMI for age is therefore vital. Evidence based guidelines and expert committee recommendations have repeatedly recommended that the BMI for age should be the basis of our definitions of paediatric overweight and obesity, 6, 9, 11, 22 and this should, in time, increase its use. Future research might lead to improvements in diagnosis using more sophisticated measures, 1 but the BMI for age is deservedly well established as the basis of our obesity diagnosis and definitions at present. Most of the widely used and recommended BMI for age cutoffs (e.g. X95th percentile) will be adequate for most purposes in clinical practice, public health, and research.
